Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ANQPV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PRN 201
|
|||||
| Synonyms |
PRN-211; PRN211
Click to Show/Hide
|
|||||
| Organization |
ProEn Therapeutics Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Colorectal cancer [ICD11:2B91]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Combination Type |
ArtBody technology
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.